cystic fibrosis educational services corp.

18 june walk
long beach, new york 11561

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 13, 2013

NYS DOS ID#
4402172

County
NASSAU

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION

Name History
2013 - CYSTIC FIBROSIS EDUCATIONAL SERVICES CORP.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Could the Rockaways Survive Another Sandy?
    By LUIS FERRÉ-SADURNÍ - Thursday Jul 13, 2017

    Residents are bracing for the worst, wondering whether measures taken so far are enough to keep devastation of the Queens community at bay.

    Source: NYT > Home Page
  • This Weekend with Gordon Deal May 13, 2017
    By info@compassmedianetworks.com (Compass Media Networks) - Saturday May 13, 2017

    A look at Cystic Fibrosis Awareness Month, a conversation with singer/songwriter Michele Williams, and where moms can get free stuff this Mothers Day.

    Source: The Wall Street Journal: Wall Street Journal This Morning
  • Vertex Shares Jump on Strong Trials of New Drugs
    Wednesday Jul 19, 2017

    Vertex Pharmaceuticals shares jumped more than 20% Wednesday after the biotech firm said three cystic-fibrosis drugs showed promise in early clinical trials.

    Source: The Wall Street Journal: U.S. Business
  • Vertex Shares Haven't Hit Their Apex
    Wednesday Jul 19, 2017

    The ferocious rally in Vertex Pharmaceuticals shares on results in early stage data for its new cystic fibrosis treatment will surely tempt some investors to exit. That may not be wise, though, as the rally is likely to continue.

    Source: The Wall Street Journal: Markets News
  • Marine Corps Plane Crash: The Victims
    By THE NEW YORK TIMES - Thursday Jul 13, 2017

    Family members and friends have begun identifying many of the 16 American service members who died on Monday when their plane crashed in rural Mississippi.

    Source: NYT > Home Page
  • New Approvals Show FDA Is Adapting to Precision Medicine
    By Frank Vinluan - Tuesday May 30, 2017

    The randomized controlled trial has long been held up as the gold standard for testing new drugs. But the nation’s top drug evaluator, Janet Woodcock, believes they aren’t necessary for all new experimental treatments. Randomized trials are long, expensive to run, and ultimately produce limited answers, she said at a medical conference last week. The […]

    Source: Xconomy New York
cystic fibrosis educational services corp long beach ny